Literature DB >> 6600908

Susceptibility of Pseudomonas paucimobilis to 24 antimicrobial agents.

D L Smalley, V R Hansen, V S Baselski.   

Abstract

Pseudomonas paucimobilis (group IIK, biotype 1) clinical isolates showed in vitro resistance to ampicillin, carbenicillin, cephalothin, cefoxitin, cefamandole, moxalactam, cefotaxime, cefoperazone, mezlocillin, azlocillin, piperacillin, and ticarcillin. Those agents to which the microbes were shown to be susceptible were tetracycline, chloramphenicol, gentamicin, tobramycin, kanamycin, amikacin, netilmicin, sisomicin, trimethoprim-sulfamethoxazole, ceftazidime, ceftriaxone, and ceftizoxime.

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6600908      PMCID： PMC184634          DOI： 10.1128/AAC.23.1.161

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  2 in total

1.  Preliminary evaluation of the autoSCAN-3, an instrument for automated reading an interpretation of microdilution trays: identification of aerobic gram-negative bacilli.

Authors:  P D Ellner; D A Myers
Journal:  J Clin Microbiol       Date:  1981-09       Impact factor: 5.948

2.  Pseudomonas paucimobilis bacteremia.

Authors:  P M Southern; A E Kutscher
Journal:  J Clin Microbiol       Date:  1981-06       Impact factor: 5.948
  2 in total
  9 in total

1.  Pseudomonas paucimobilis peritonitis in a patient on CAPD successfully treated with ciprofloxacin and netilmicin.

Authors:  G Phillips; L W Fleming; W K Stewart
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-08       Impact factor: 3.267

2.  Comparative activity of trovafloxacin, alone and in combination with other agents, against gram-negative nonfermentative rods.

Authors:  M A Visalli; S Bajaksouzian; M R Jacobs; P C Appelbaum
Journal:  Antimicrob Agents Chemother       Date:  1997-07       Impact factor: 5.191

3.  Susceptibilities of non-Pseudomonas aeruginosa gram-negative nonfermentative rods to ciprofloxacin, ofloxacin, levofloxacin, D-ofloxacin, sparfloxacin, ceftazidime, piperacillin, piperacillin-tazobactam, trimethoprim-sulfamethoxazole, and imipenem.

Authors:  S K Spangler; M A Visalli; M R Jacobs; P C Appelbaum
Journal:  Antimicrob Agents Chemother       Date:  1996-03       Impact factor: 5.191

4.  [Septic monarthritis caused by Sphingomonas paucimobilis].

Authors:  G Dischereit; M Burk; K Storck-Müller; U Lange
Journal:  Z Rheumatol       Date:  2013-10       Impact factor: 1.372

5.  Community-acquired bloodstream infection caused by Pseudomonas paucimobilis: case report and review of the literature.

Authors:  A J Morrison; J A Shulman
Journal:  J Clin Microbiol       Date:  1986-11       Impact factor: 5.948

Review 6.  Moxalactam (latamoxef). A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  A A Carmine; R N Brogden; R C Heel; J A Romankiewicz; T M Speight; G S Avery
Journal:  Drugs       Date:  1983-10       Impact factor: 9.546

Review 7.  Netilmicin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  D M Campoli-Richards; S Chaplin; R H Sayce; K L Goa
Journal:  Drugs       Date:  1989-11       Impact factor: 9.546

8.  An evaluation of microbial and chemical contamination sources related to the deterioration of tap water quality in the household water supply system.

Authors:  Yoonjin Lee
Journal:  Int J Environ Res Public Health       Date:  2013-09-06       Impact factor: 3.390

9.  A Rare Case of Sphingomonas paucimobilis Spondylodiscitis Managed Surgically.

Authors:  Areena Dsouza; Abhinandan Reddy Mallepally; Nandan Amrit Marathe; Kalidutta Das; Bibhudendu Mohaptra
Journal:  J Orthop Case Rep       Date:  2021-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.